EXTENSIVE STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immunotherapy combo shows promise for tough lung cancer
Disease control CompletedThis Phase 3 trial tested whether adding an experimental immunotherapy drug called HLX10 to standard chemotherapy could help people with extensive-stage small cell lung cancer live longer. The study enrolled 585 people who had not received prior treatment. Participants were rando…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 23, 2026 21:03 UTC
-
New combo therapy shows promise for aggressive lung cancer
Disease control CompletedThis study tested whether adding an experimental drug (BMS-986012) to standard chemotherapy and immunotherapy could help people with advanced small cell lung cancer live longer without their cancer growing. The trial involved 135 newly diagnosed patients. Researchers measured saf…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Real-World check: does zepzelca help advanced lung cancer patients?
Disease control CompletedThis study followed 272 adults with extensive-stage small cell lung cancer who were taking the drug Zepzelca. Researchers wanted to see how well the drug worked and how safe it was in real-world settings, not just in controlled trials. The goal was to measure tumor shrinkage, sur…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New combo vaccine shows promise in halting aggressive lung cancer
Disease control CompletedThis study tested a maintenance treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer. After standard chemotherapy and an immunotherapy drug, patients received a personalized vaccine made from their own immune cells, plus continued immunotherapy.…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
Talking through cancer: can couples therapy ease the emotional toll?
Symptom relief CompletedThis study tested a program that teaches couples communication skills when one partner has advanced cancer. About 440 patients and their partners took part, with half receiving the training and half getting general healthy living information. The goal was to see if the training c…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 22, 2026 12:05 UTC
-
Team nursing approach shows promise for lung cancer patients on immunotherapy
Symptom relief CompletedThis study tested a team-based nursing program for 200 people with advanced small cell lung cancer receiving chemotherapy plus immunotherapy. The program included close monitoring for side effects, help with medication adherence, nutrition and exercise support, and psychological …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Shanxi Province Cancer Hospital • Aim: Symptom relief
Last updated Jun 11, 2026 12:11 UTC